Two Sigma Securities’s Carisma Therapeutics CARM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.03K | Buy |
17,952
+6,338
| +55% | +$2.48K | ﹤0.01% | 1331 |
|
|
2025
Q1 | $3.6K | Buy |
11,614
+182
| +2% | +$56 | ﹤0.01% | 1313 |
|
|
2024
Q4 | $4.79K | Buy |
+11,432
| New | +$4.79K | ﹤0.01% | 1298 |
|
|
2023
Q1 | – | Sell |
-4,185
| Closed | -$51K | – | 1395 |
|
|
2022
Q4 | $51K | Buy |
+4,185
| New | +$51K | ﹤0.01% | 952 |
|
|
2022
Q3 | – | Sell |
-1,989
| Closed | -$32K | – | 1423 |
|
|
2022
Q2 | $32K | Buy |
1,989
+1,125
| +130% | +$18.1K | ﹤0.01% | 934 |
|
|
2022
Q1 | $10K | Sell |
864
-2,847
| -77% | -$33K | ﹤0.01% | 1046 |
|
|
2021
Q4 | $60K | Sell |
3,711
-2,821
| -43% | -$45.6K | ﹤0.01% | 754 |
|
|
2021
Q3 | $104K | Buy |
+6,532
| New | +$104K | ﹤0.01% | 632 |
|
|
2020
Q4 | – | Sell |
-1,021
| Closed | -$29K | – | 716 |
|
|
2020
Q3 | $29K | Buy |
+1,021
| New | +$29K | ﹤0.01% | 439 |
|
|
2019
Q3 | – | Sell |
-1,982
| Closed | -$59K | – | 781 |
|
|
2019
Q2 | $59K | Buy |
+1,982
| New | +$59K | ﹤0.01% | 697 |
|
|
2018
Q3 | – | Sell |
-573
| Closed | -$22K | – | 1223 |
|
|
2018
Q2 | $22K | Buy |
+573
| New | +$22K | ﹤0.01% | 974 |
|
|
2018
Q1 | – | Sell |
-3,258
| Closed | -$53K | – | 1201 |
|
|
2017
Q4 | $53K | Buy |
+3,258
| New | +$53K | ﹤0.01% | 816 |
|
|
2017
Q3 | – | Sell |
-874
| Closed | -$27K | – | 901 |
|
|
2017
Q2 | $27K | Buy |
+874
| New | +$27K | 0.01% | 764 |
|
|
2016
Q3 | – | Sell |
-1,271
| Closed | -$42K | – | 667 |
|
|
2016
Q2 | $42K | Buy |
1,271
+99
| +8% | +$3.27K | 0.02% | 345 |
|
|
2016
Q1 | $7K | Buy |
+1,172
| New | +$7K | 0.01% | 271 |
|